Zusammenfassung
Die Komorbidität zwischen somatischen und psychiatrischen Erkrankungen ist nach wie vor weder ausreichend erforscht noch findet sie ausreichende Beachtung in der klinischen Praxis (Maier u. Falkai 1999). Der folgende Beitrag beschäftigt sich mit dem gemeinsamen Auftreten der Major Depression und jeweils einer von drei sehr unterschiedlichen Erkrankungen aus dem nervenärztlichen Stoffgebiet: Temporallappenepilepsie, Apoplex und Morbus Parkinson.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Amann B, Erfurth A, Back T, Grunze H (1999) Severe therapy refractory depression as initial manifestation of Parkinson disease. Psychiatr Prax 26:45–47.
American Psychiatric Association (1998) Diagnostisches und Statistisches Manual Psychischer Störungen. DSM-IV, 2. Aufl. Hogrefe, Göttingen.
Andersen G, Vestergaard K, Riis JO (1993) Citalopram for post-stroke pathological crying. Lancet 342 (8875):837–839.
Andersen G, Vestergaard K, Lauritzen L (1994) Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke 25:1099–1104.
Andersen G (1995) Treatment of uncontrolled crying after stroke. Drugs Aging 6:105–111.
Andersen G (1997) Post-stroke depression: diagnosis and incidence. Eur Psychiatry 12 (Suppl 3):255–260.
Bader JP, Hell D (1998) Parkinson-Syndrom und Depression. Fortschr Neurol Psychiat 66:303–312.
Bazire S (1999) Psychotropic drug directory. Quay, Snow Hill.
Bleuler E (1943) Lehrbuch der Psychiatrie. Springer, Berlin.
Brown RG, MacCarthy B (1990) Psychiatric morbidity in patients with Parkinson’s disease. Psychol Med 20:77–87.
Burke WJ, Peterson J, Rubin EH (1988) Electroconvulsive therapy in the treatment of combined depression and Parkinson’s disease. Psychosomatics 29:341–346.
Chaslin P (1895) La Confusion mentale primitive. Asselin et Houzeau, Paris.
Cummings JL (1992) Depression and Parkinson’s disease: a review. Am J Psychiatry 149:443–454.
Dahmen N, Marx J, Hopf HC, Tettenborn B, Roder R (1999) Therapy of early poststroke depression with venlafaxine: safety, tolerability, and efficacy as determined in an open, uncontrolled clinical trial. Stroke 30:691–692.
Dam M, Tonin P, De Boni A et al. (1996) Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke 27:1211–1214.
Douyon R, Serby M, Klutchko B, Rotrosen J (1989) ECT and Parkinson’s disease revisited: a “naturalistic“ study. Am J Psychiatry 146:1451–1455.
Evans DL, Staab JP, Petitto JM et al. (1999) Depression in the medical setting: biopsychological interactions and treatment considerations. J Clin Psychiatry 60 (Suppl 4):40–55.
Falkai P, Kühn K-U, Maier W, Elger CE (2001) Psychopathology of pre- and postoperative patients with temporallobeepilepsy. (Submitted).
Fedoroff JP, Lipsey JR, Starkstein SE, Forrester A, Price TR, Robinson RG (1991) Phenomenological comparisons of major depression following stroke, myocardial infarction or spinal cord lesions. J Affect Disord 22:83–89.
Gainotti G, Azzoni A, Marra C (1999) Frequency, phenomenology and anatomical-clinical correlates of major post-stroke depression. Br J Psychiatry 175:163–167.
Garnett WR (2000) Antiepileptic drug treatment: outcomes and adherence. Pharmacotherapy 20:191–199.
Gordon WA, Hibbard MR (1997) Poststroke depression: an examination of the literature. Arch Phys Med Rehabil 78:658–663.
Haltenhof H, Schröter C (1994) Depression beim Parkinson-Syndrom - eine Literatur0übersicht. Fortschr Neurol Psychiatr 62:94–101.
Hantz P, Caradoc-Davies G, Caradoc-Davies T, Weatherall M, Dixon G (1994) Depression in Parkinson’s disease. Am J Psychiatry 151:1010–1014.
Helmstaedter C, Kurthen M, Lux S, Johanson K, Quiske A, Schramm J, Elger CE (2000) Temporallappenepilepsie. Längsschnittliche klinische, neuropsychologische und psychosoziale Entwicklung operativ und konservativ behandelter Patienten. Nervenarzt 71: 629–642.
Herrmann N, Black SE, Lawrence J, Szekely C, Szalai JP (1998) The Sunnybrook Stroke Study: a prospective study of depressive symptoms and functional outcome. Stroke 29: 618–624.
Hoogendijk WJ, Sommer IE, Tissingh G, Deeg Dj, Wolters EC (1998) Depression in Parkinson’s disease. The impact of symptom overlap on prevalence. Psychosomatics 39:416–421.
Hopf HC, Schlegel S (1995) Depression im Gefolge von Hirninfarkten. In: Möller HJ, Przuntek H, Laux G, Büttner T (Hrsg) Therapie im Grenzgebiet von Psychiatrie und Neurologie. Springer, Berlin Heidelberg New York Tokyo.
Hosking SG, Marsh NV, Friedman PJ (1996) Poststroke depression: prevalence, course, and associated factors. Neuropsychol Rev 6:107–133.
Huber G (1974) Psychiatrie. Lehrbuch für Studium und Weiterbildung. Schattauer, Stuttgart.
International League Against Epilepsy, ILAE (1989) Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 30: 389–399.
Janet P (1924) Leçons sur les Maladys du Système Nerveux. Delahaye, Paris.
Klaassen T, Verhey FR, Sneijders GH, Rozendaal N, de Vet HC, van Praag HM (1995) Treatment of depression in Parkinson’s disease: a meta-analysis. J Neuropsychiatry Clin Neurosci 7:281–286.
Kühn K-U, Quednow BB, Römer C, Falkai P, Elger CE, Maier W (2001) Antidepressive treatment in patients with temporallobeepilepsy. (Submitted).
Levin BE, Katzen HL (1995) Early cognitive changes in Parkinson’s disease. In: Weiner WJ, Lang AE (eds) Behavioral neurology of movement disorders. Advances in Neurology. Raven, New York.
Lewis AJ (1934) Melancholia: a historical review. J Ment Sci 80:1–42.
Lipsey JR, Spencer WC, Rabins PV, Robinson RG (1986) Phenomenological comparison of poststroke depression and functional depression. Am J Psychiatry 143:527–529.
Maier W, Falkai P (1999) The epidemiology of comorbidity between depression, anxiety disorders and somatic diseases. Int Clin Psychopharmacol 14 (Suppl 2): 1–6.
Mayeux R, Denaro J, Hemenegildo N, Marder K, Tang MX, Cote LJ, Stern Y (1992) A population-based investigation of Parkinson’s disease with and without dementia. Relationship to age and gender. Arch Neurol 49:492–497.
Meschia JF, Bruno A (1998) Post-stroke complications, epidemiology and prospects for pharmacological intervention during rehabilitaton. CNS Drugs 9:357–370.
Mindham RH (1970) Psychiatric symptoms in Parkinsonism. J Neurol Neurosurg Psychiatry 33:188–191.
Morris PL, Robinson RG, Raphael B (1990) Prevalence and course of depressive disorders in hospitalized stroke patients. A double-blind placebo-controlled study. Int J Psychiatry Med 20:349–364.
Murray GB, Shea V, Conn DK (1986) Electroconvulsive therapy for poststroke depression. J Clin Psychiatry 47:258–260.
Neau JP, Ingrand P, Mouille-Brachet C, Rosier MP, Couderq C, Alvarez A, Gil R (1998) Functional recovery and social outcome after cerebral infarction in young adults. Cerbrovasc Dis 8:296–302.
Parkinson J (1817) An Essay on the Shaking Palsy. Sherwood, Neely & Jones, London.
Poewe W, Luginger E (1999) Depression in Parkinson’s disease, Impediments to recognition and treatment options. Neurology 52 (Suppl 3):2–6.
Robbins AH (1976) Depression in patients with Parkinsonism. Br J Psychiatry 128:141–145.
Robertson MM, Trimble MR, Townsend HR (1987) Phenomenology of depression in epilepsy. Epilepsia 28:364–372.
Robertson MM, Katona CLE (eds) (1997) Depression and physical illness. Wiley, Chichester.
Robinson RG, Travella JI (1996) Neuropsychiatry of mood disorders. In: Fogel BS, Schiffer RB, Rao SM (eds) Neuropsychiatry. Davis, Baltimore.
Robinson RG, Paradiso S (1999) Psychiatric aspects of cerebral vascular disorders. In: Robinson RG, Yates WE (eds) Psychiatric treatment of the medically ill. Dekker, New York.
Santamaria J, Tolosa E, Valles A (1986) Parkinson’s disease with depression: a possible sub-group of idiopathic parkinsonism. Neurology 36:1130–1133.
Schubert DSP, Burns R, Paras W, Sioson E (1992) Increase of medical hospital length of stay by depression in stroke and amputation patients: a pilot study. Psychother Psychosom 57:61–66.
Series HG (1992) Drug treatment of depression in medically ill patients. J Psychosom Res 36:1–16.
Singh A, Black SE, Herrmann N, Leibovitch FS, Ebert PL, Lawrence J, Szalai JP (2000) Functional and neuroanatomic correlations in poststroke depression: the Sunnybrook Stroke Study. Stroke 31:637–644.
Starkstein SE, Robinson RG (1989) Affective disorders and cerebral vascular disease. Br J Psychiatry 154:170–182.
Starkstein SE, Preziosi TJ, Bolduc PL, Robinson RG (1990) Depression in Parkinson’s disease. J Nerv Ment Dis 178:27–31.
Starkstein SE, Robinson RG (1992) Neuropsychiatric aspects of cerebral vascular disorders. In: Yudofsky SC, Hales RE (eds) Textbook of Neuropsychiatry, 2nd edn. American Psychiatric Press, Washington.
Starkstein SE, Petracca G, Chemerinski E, Teson A, Sabe L, Merello M, Leiguarda R (1998) Depression in classic versus akinetic-rigid Parkinson’s disease. Mov Disord 13:29–33.
Starkstein SE, Petracca G (1999) Parkinson’s Disease. In: Robinson RG, Yates WE (eds) Psychiatric treatment of the medically ill. Dekker, New York.
Struppler A (2000) Erkrankungen der Basalganglien. In: Förstel H (Hrsg) Klinische Neuro-Psychiatrie: Thieme, Stuttgart.
Tom T, Cummings JL (1999) Depression in Parkinson’s disease, pharmacological characteristics and treatment. Drugs Aging 12:55–74.
Walden J, Wegerer J, Berger M (1996) Wirksamkeit von Antiepileptika bei psychischen Erkrankungen. EEG-Labor 18:32–47.
Wiart L, Petit H, Joseph PA, Mazaux JM, Barat M (2000) Fluoxetine in early poststroke depression. Stroke 31:1829.
Wettterling T (2000) Zerebrovaskuläre Erkrankungen. In: Förstel H (Hrsg) Klinische Neuro-Psychiatrie: Thieme, Stuttgart.
Zesiewicz, TA, Gold M, Chari G, Hauser RA (1999) Current issues in depression in Parkinson’s disease. Am J Geriatr Psychiatry 7:110–118.
Ziegler B (1996) Zur Psychopathologie des Parkinson-Syndroms. Klinikarzt 9/25:266–270.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Kühn, KU. (2002). Major Depression bei organischen Grunderkrankungen. In: Laux, G. (eds) Depression 2000. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59394-9_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-59394-9_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63963-0
Online ISBN: 978-3-642-59394-9
eBook Packages: Springer Book Archive